Fennec Pharmaceuticals to Report Third Quarter 2024 Financial Results[...]
Vontier Reports Strong Third Quarter 2024 Results and Narrows Full Year[...]
Matinas BioPharma Holdings Inc.
Matinas BioPharma Announces the Termination of MAT2203 Partnership[...]
10/30/2024 | Press release | Distributed by Public on 10/30/2024 14:57
Please select the service you want to use:
Smartlinks | CalciMedica Inc. | News | Health | Finance | Stock Markets | Security Markets | Stock Markets | Security Markets | Company News | Issue of Shares and Capital Increase | Public Share Offering | Biotechnology and Medical Research Companies | NYSE American | NYSE ARCA Equities | Nasdaq Capital Market | Cboe BZX Exchange | Cboe BYX Exchange | Cboe EDGA Exchange | Cboe EDGX Exchange | FINRA Alternative Display Facility (ADF) | Nasdaq BX | Nasdaq PSX | NYSE Chicago
Back
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact